financetom
Business
financetom
/
Business
/
HSBC to Reportedly Scale Back Investment Banking in Europe, UK, and Americas
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HSBC to Reportedly Scale Back Investment Banking in Europe, UK, and Americas
Jan 28, 2025 3:55 AM

06:20 AM EST, 01/28/2025 (MT Newswires) -- HSBC ( HSBC ) plans to wind down its mergers and acquisitions and equity underwriting operations in the UK, Europe, and the Americas, shifting its focus to Asia and the Middle East, multiple news outlets reported Tuesday, citing an internal staff memo.

The restructuring aims to reduce costs, improve accountability, and reallocate resources to regions where the bank generates the majority of its profits, these reports said.

HSBC ( HSBC ) will transition to a financing-focused model to strengthen its position in areas such as debt markets and strategic equity finance, Reuters reported, quoting the memo.

While the exact number of job cuts is unknown, some employees are expected to be reassigned to positions in Asia and the Middle East, these reports said.

An HSBC ( HSBC ) spokesperson told MT Newswires that the bank is finalizing a review of its investment banking division, which will retain targeted M&A and equity capital markets capabilities in Asia and the Middle East while winding down these activities in the UK, Europe, and the US, in compliance with local regulations.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Retail rally running out of steam after record streak, J.P. Morgan warns
Retail rally running out of steam after record streak, J.P. Morgan warns
Nov 10, 2025
(Reuters) -Retail investors are dialing back their risky bets after the longest bullish streak in recent years, J.P. Morgan analysts wrote in a note, marking a shift in sentiment that could sap momentum in high-flying U.S. stocks. The brokerage's readout from Friday showed a drop in bullish options bets, with call volumes slipping compared to puts, after roughly 140 days...
ADC Therapeutics Q3 net income beats analyst expectations
ADC Therapeutics Q3 net income beats analyst expectations
Nov 10, 2025
Overview * ADC Therapeutics ( ADCT ) Q3 net income and income from operations beat analyst expectations * Net product revenues for Q3 2025 declined due to lower sales volume * Completed $60 mln PIPE financing to expand ZYNLONTA and strengthen balance sheet Outlook * ADC Therapeutics ( ADCT ) expects LOTIS-7 data by end of 2025 * Company anticipates...
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Nov 10, 2025
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. ( RVTY ) , today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end...
Cabaletta Bio reports smaller-than-expected Q3 loss
Cabaletta Bio reports smaller-than-expected Q3 loss
Nov 10, 2025
Overview * Company advancing rese-cel clinical trials with promising data for autoimmune diseases * Cabaletta expects cash reserves to fund operations into the second half of 2026 Outlook * Cabaletta plans BLA submission for rese-cel in 2027 * Company expects FDA alignment on cohort designs by end of 2025 * Cabaletta anticipates enrollment in registrational cohorts in 2026 Result Drivers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved